House bill HR7384-118

Energy and Commerce Committee

Creating Hope Reauthorization Act of 2024

• Last activity on Feb 16, 2024

• Introduced Feb 15, 2024

• By Rep. McCaul, Michael T. [R-TX-10]

Support this bill

Main Subject: Health

Creating Hope Reauthorization Act of 2024

This bill extends until FY2029 a Food and Drug Administration program that awards priority review vouchers to manufacturers of drugs that treat rare pediatric diseases. (A priority review voucher entitles the voucher holder to priority review of a single human drug application.)

House committee actions Actions

Committee
Feb. 16 2024	Referred to the Subcommittee on Health.

House floor actions Actions

IntroReferral
Feb. 15 2024	Referred to the House Committee on Energy and Commerce.

Library of Congress Actions

IntroReferral
Feb. 15 2024	Introduced in House Introduced in House

House bill HR7384-118

Creating Hope Reauthorization Act of 2024

Promote the cause!

Or use this QR code